CORRECTING and REPLACING Bioanalytical Systems to Release Fourth Quarter & Fiscal 2012 Results Thurs

CORRECTING and REPLACING Bioanalytical Systems to Release Fourth Quarter & Fiscal 2012 Results Thursday, December 27, 2012; Conference Call & Webcast Set For 1:00 p.m. EST

WEST LAFAYETTE, Ind.--(BUSINESS WIRE)-- In headline and first graph of release dated December 18, 2012, conference call time is changing to 1 PM EST (sted 11 AM EST).

The corrected release reads:


BIOANALYTICAL SYSTEMS TO RELEASE FOURTH QUARTER & FISCAL 2012 RESULTS THURSDAY, DECEMBER 27, 2012; CONFERENCE CALL & WEBCAST SET FOR 1:00 P.M. EST

Bioanalytical Systems, Inc. (Nasdaq: BASI) will release financial results for the fourth quarter and fiscal year 2012 ended September 30, 2012 at approximately 8:30 a.m. EST on Thursday, December 27, 2012. BASi has scheduled a conference call at 1:00 p.m. EST that morning to discuss its results for the quarter and fiscal 2012. To participate in the call, dial 866.713.8310, passcode #83355796.

A simultaneous webcast of the conference call may be accessed online from the Investors tab at www.BASInc.com. The webcast will be available for replay after 2:00 p.m. EST at this same Internet address. For a telephone replay, dial 888.286.8010, passcode #41234644 after 2:00 p.m. EST.

About Bioanalytical Systems, Inc.

BASi is a pharmaceutical development company providing contract research services and monitoring instruments to the world's leading drug development companies and medical research organizations. The company focuses on developing innovative services and products that increase efficiency and reduce the cost of taking a new drug to market. Visit www.BASinc.com for more about BASi.

This release may contain forward-looking statements that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to changes in the market and demand for our products and services, the development, marketing and sales of products and services, changes in technology, industry standards and regulatory standards, and various market and operating risks detailed in the company's filings with the Securities and Exchange Commission.

anImage


Bioanalytical Systems, Inc.
Jacqueline Lemke, 765-497-5829
Interim President & CEO and CFO
jlemke@BASinc.com
or
Berkman Associates
Neil Berkman, 310-477-3118
info@berkmanassociates.com

KEYWORDS:   United States  North America  Indiana

INDUSTRY KEYWORDS:

The article CORRECTING and REPLACING Bioanalytical Systems to Release Fourth Quarter & Fiscal 2012 Results Thursday, December 27, 2012; Conference Call & Webcast Set For 1:00 p.m. EST originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.


Increase your money and finance knowledge from home

Introduction to Preferred Shares

Learn the difference between preferred and common shares.

View Course »

Investing in Emerging Markets

Learn to invest in a globalized world.

View Course »

Add a Comment

*0 / 3000 Character Maximum